Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Lei

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019
[Expression of CD45 in newly diagnosed multiple myeloma and the relationship with prognosis]J Shi, Z M Zhu, K Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2019
[Prognostic significance of CD56 and CD117 expression in patients with newly diagnosed multiple myeloma treated with bortezomib-based first-line therapy]J Shi, K Sun, Z M Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Comparative study of molecular response of first-line and second-line nilotinib in patients with chronic-phase chronic myelogenous leukemia]H Xu, P Wang, R J Ma, et al.
Zhonghua Yi Xue Za Zhi|September 18, 2018
[Clinical significance of the ratio of serum beta-CTX/PINP in multiple myeloma bone diseases and bone metastases]S W Yang, R J Ma, J J Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 6, 2018
[Significance of changed levels of TRACP-5b, PINP and vitamin D3 before and after the treatment of myeloma disease]R J Ma, Z M Zhu, X L Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 12, 2021
[Correlation analysis of central nervous system relapse and cell biological characteristics in acute promyelocytic leukemia]S W Yang, R J Ma, X L Yuan, et al.
Zhonghua Yi Xue Za Zhi|July 14, 2020
[The influence and clinical significance of proteasome inhibitor on serum bone metabolite markers in patients with myeloma bone disease]R J Ma, S W Yang, X L Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[Comparison of different styles of allogeneic hematopoietic stem cell transplantation as first-line treatment treated with severe aplastic anemia in children and adolescents]S W Yang, R J Ma, J J Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 6, 2020
[Clinical study on factor Ⅷ inhibitor in children with hemophilia A]B J Shang, S W Yang, P C Lei, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia]R J Ma, Z M Zhu, X L Yuan, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019
[Expression of CD45 in newly diagnosed multiple myeloma and the relationship with prognosis]J Shi, Z M Zhu, K Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2019
[Prognostic significance of CD56 and CD117 expression in patients with newly diagnosed multiple myeloma treated with bortezomib-based first-line therapy]J Shi, K Sun, Z M Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Comparative study of molecular response of first-line and second-line nilotinib in patients with chronic-phase chronic myelogenous leukemia]H Xu, P Wang, R J Ma, et al.
Zhonghua Yi Xue Za Zhi|September 18, 2018
[Clinical significance of the ratio of serum beta-CTX/PINP in multiple myeloma bone diseases and bone metastases]S W Yang, R J Ma, J J Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 6, 2018
[Significance of changed levels of TRACP-5b, PINP and vitamin D3 before and after the treatment of myeloma disease]R J Ma, Z M Zhu, X L Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 12, 2021
[Correlation analysis of central nervous system relapse and cell biological characteristics in acute promyelocytic leukemia]S W Yang, R J Ma, X L Yuan, et al.
Zhonghua Yi Xue Za Zhi|July 14, 2020
[The influence and clinical significance of proteasome inhibitor on serum bone metabolite markers in patients with myeloma bone disease]R J Ma, S W Yang, X L Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[Comparison of different styles of allogeneic hematopoietic stem cell transplantation as first-line treatment treated with severe aplastic anemia in children and adolescents]S W Yang, R J Ma, J J Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 6, 2020
[Clinical study on factor Ⅷ inhibitor in children with hemophilia A]B J Shang, S W Yang, P C Lei, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia]R J Ma, Z M Zhu, X L Yuan, et al.
Pageof 3